{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T19:56:13Z","timestamp":1793822173269,"version":"4.6.1"},"reference-count":68,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,9]]},"abstract":"<jats:title>SUMMARY<\/jats:title>\n                  <jats:p>The purpose of this document is to review currently available management options, general principles, and counseling approaches for reproductive-aged patients requesting menstrual suppression. It includes considerations for unique populations, including adolescents, patients with physical or cognitive disabilities or both, and those with limited access to health care. Gynecologists should be familiar with the use of hormonal therapy for menstrual suppression (including combined oral contraceptive pills, combined hormonal patches, vaginal rings, progestin-only pills, depot medroxyprogesterone acetate, the levonorgestrel-releasing intrauterine device, and the etonogestrel implant). Approaches to counseling should be individualized based on patient preferences and goals, average treatment effectiveness, and contraindications or risk factors for adverse events. Counseling regarding the choice of hormonal medication for menstrual suppression should be approached with the utmost respect for patient autonomy and be free of coercion. Complete amenorrhea may be difficult to achieve; thus, obstetrician\u2013gynecologists and other clinicians should counsel patients and caregivers, if applicable, about realistic expectations.<\/jats:p>","DOI":"10.1097\/aog.0000000000004899","type":"journal-article","created":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T08:18:23Z","timestamp":1660897103000},"page":"528-541","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":92,"title":["ACOG Clinical Consensus No. 3: General Approaches to Medical Management of Menstrual Suppression"],"prefix":"10.1097","volume":"140","author":[{"name":"American College of Obstetricians and Gynecologists\u2019 Committee on Clinical Consensus\u2013Gynecology","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260916","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/GCO.0000000000000098","article-title":"Menstrual suppression for adolescents","volume":"26","author":"Altshuler","year":"2014","journal-title":"Curr Opin Obstet Gynecol"},{"key":"R2-20260916","first-page":"653","article-title":"Continuous combination oral contraceptive pills to eliminate withdrawal bleeding: a randomized trial","volume":"101","author":"Miller","year":"2003","journal-title":"Obstet Gynecol"},{"key":"R3-20260916","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1097\/AOG.0000000000004209","article-title":"Options for prevention and management of menstrual bleeding in adolescent patients undergoing cancer treatment. ACOG Committee Opinion No. 817. American College of Obstetricians and Gynecologists","volume":"137","year":"2021","journal-title":"Obstet Gynecol"},{"key":"R4-20260916","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/AOG.0b013e3181e8b073","article-title":"Management of endometriosis. Practice Bulletin No. 114. American College of Obstetricians and Gynecologists","volume":"116","year":"2010","journal-title":"Obstet Gynecol"},{"key":"R5-20260916","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/AOG.0b013e318262e320","article-title":"Diagnosis of abnormal uterine bleeding in reproductive-aged women. Practice Bulletin No. 128. American College of Obstetricians and Gynecologists","volume":"120","year":"2012","journal-title":"Obstet Gynecol"},{"key":"R6-20260916","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/01.AOG.0000431815.52679.bb","article-title":"Management of abnormal uterine bleeding associated with ovulatory dysfunction. Practice Bulletin No. 136. American College of Obstetricians and Gynecologists","volume":"122","year":"2013","journal-title":"Obstet Gynecol"},{"key":"R7-20260916","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1097\/AOG.0000000000003411","article-title":"Screening and management of bleeding disorders in adolescents with heavy menstrual bleeding. ACOG Committee Opinion No. 785. American College of Obstetricians and Gynecologists","volume":"134","year":"2019","journal-title":"Obstet Gynecol"},{"key":"R8-20260916","first-page":"e157","article-title":"Polycystic ovary syndrome. ACOG Practice Bulletin No. 194 [published erratum appears in Obstet Gynecol 2020;136:638]. American College of Obstetricians and Gynecologists","volume":"131","year":"2018","journal-title":"Obstet Gynecol"},{"key":"R9-20260916","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1097\/AOG.0000000000004401","article-title":"Management of symptomatic uterine leiomyomas. ACOG Practice Bulletin No. 228. American College of Obstetricians and Gynecologists","volume":"137","year":"2021","journal-title":"Obstet Gynecol"},{"key":"R10-20260916","first-page":"523","article-title":"Clinical Consensus methodology. American College of Obstetricians and Gynecologists","volume":"138","year":"2021","journal-title":"Obstet Gynecol"},{"key":"R13-20260916","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.contraception.2004.11.007","article-title":"Safety and efficacy of Implanon, a single-rod implantable contraceptive containing etonogestrel. Implanon US Study Group","volume":"71","author":"Funk","year":"2005","journal-title":"Contraception"},{"key":"R14-20260916","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.contraception.2006.03.008","article-title":"Changes in bleeding patterns with depot medroxyprogesterone acetate subcutaneous injection 104 mg","volume":"74","author":"Arias","year":"2006","journal-title":"Contraception"},{"key":"R15-20260916","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1017\/S1742058X11000130","article-title":"Structural racism and health inequities: old issues, new directions","volume":"8","author":"Gee","year":"2011","journal-title":"Du Bois Rev"},{"key":"R16-20260916","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s12978-018-0561-0","article-title":"There might be blood: a scoping review on women's responses to contraceptive-induced menstrual bleeding changes","volume":"15","author":"Polis","year":"2018","journal-title":"Reprod Health"},{"key":"R17-20260916","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.contraception.2009.05.128","article-title":"Continuous, daily levonorgestrel\/ethinyl estradiol vs. 21-day, cyclic levonorgestrel\/ethinyl estradiol: efficacy, safety and bleeding in a randomized, open-label trial","volume":"80","author":"Teichmann","year":"2009","journal-title":"Contraception"},{"key":"R19-20260916","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.contraception.2005.08.003","article-title":"Effective use of hormonal contraceptives: part I: combined oral contraceptive pills","volume":"73","author":"Curtis","year":"2006","journal-title":"Contraception"},{"key":"R20-20260916","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.whi.2004.08.005","article-title":"Evidence about extending the duration of oral contraceptive use to suppress menstruation","volume":"14","author":"Hitchcock","year":"2004","journal-title":"Womens Health Issues"},{"key":"R21-20260916","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2165\/00024677-200504030-00002","article-title":"Extended-cycle oral contraception: a new option for routine use","volume":"4","author":"Nelson","year":"2005","journal-title":"Treat Endocrinol"},{"key":"R22-20260916","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2147\/IJWH.S4886","article-title":"New low-dose, extended-cycle pills with levonorgestrel and ethinyl estradiol: an evolutionary step in birth control","volume":"2","author":"Nelson","year":"2010","journal-title":"Int J Womens Health"},{"key":"R23-20260916","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ogc.2007.01.001","article-title":"Extended cycle combined hormonal contraception","volume":"34","author":"Steinauer","year":"2007","journal-title":"Obstet Gynecol Clin North Am"},{"key":"R24-20260916","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1080\/09513590.2020.1725963","article-title":"Extended-cycle versus conventional treatment with a combined oral contraceptive containing ethinylestradiol (30 \u03bcg) and levonorgestrel (150 \u03bcg) in a randomized controlled trial","volume":"36","author":"Hadji","year":"2020","journal-title":"Gynecol Endocrinol"},{"key":"R25-20260916","doi-asserted-by":"crossref","first-page":"631","DOI":"10.2147\/IJWH.S46680","article-title":"Menstrual suppression: current perspectives","volume":"6","author":"Hillard","year":"2014","journal-title":"Int J Womens Health"},{"key":"R27-20260916","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1001\/jama.285.18.2347","article-title":"Evaluation of contraceptive efficacy and cycle control of a transdermal contraceptive patch vs an oral contraceptive: a randomized controlled trial. ORTHO EVRA\/EVRA 004 Study Group","volume":"285","author":"Audet","year":"2001","journal-title":"JAMA"},{"key":"R28-20260916","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1097\/01.AOG.0000160430.61799.f6","article-title":"Extended use of transdermal norelgestromin\/ethinyl estradiol: a randomized trial","volume":"105","author":"Stewart","year":"2005","journal-title":"Obstet Gynecol"},{"key":"R29-20260916","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jpag.2007.10.008","article-title":"Menstrual suppression for adolescents with developmental disabilities","volume":"22","author":"Savasi","year":"2009","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"R31-20260916","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/j.jpag.2019.04.007","article-title":"Hormonal contraceptives, intrauterine devices, gonadotropin-releasing hormone analogues and testosterone: menstrual suppression in special adolescent populations","volume":"32","author":"Pradhan","year":"2019","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"R32-20260916","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/AOG.0b013e3181842071","article-title":"Frequency and management of breakthrough bleeding with continuous use of the transvaginal contraceptive ring: a randomized controlled trial","volume":"112","author":"Sulak","year":"2008","journal-title":"Obstet Gynecol"},{"key":"R33-20260916","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/01.AOG.0000175144.08035.74","article-title":"Extended regimens of the contraceptive vaginal ring: a randomized trial","volume":"106","author":"Miller","year":"2005","journal-title":"Obstet Gynecol"},{"key":"R34-20260916","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.contraception.2009.05.004","article-title":"Extended regimens of the vaginal contraceptive ring: cycle control","volume":"80","author":"Guazzelli","year":"2009","journal-title":"Contraception"},{"key":"R35-20260916","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.contraception.2006.10.009","article-title":"Bleeding patterns of women using extended regimens of the contraceptive vaginal ring","volume":"75","author":"Barreiros","year":"2007","journal-title":"Contraception"},{"key":"R36-20260916","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jpag.2013.09.002","article-title":"Retrospective review of norethindrone use in adolescents","volume":"27","author":"Santos","year":"2014","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"RR-3","key":"R37-20260916","first-page":"1","article-title":"U.S. medical eligibility criteria for contraceptive use","volume":"65","author":"Curtis","year":"2016","journal-title":"MMWR Recomm Rep"},{"key":"R40-20260916","first-page":"591","article-title":"Inducement of therapeutic amenorrhea in mentally retarded women: two-year follow-up study","volume":"90","author":"M\u00f6ls\u00e4","year":"1986","journal-title":"Am J Ment Defic"},{"key":"R43-20260916","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1001\/archpedi.160.1.40","article-title":"Weight gain in obese and nonobese adolescent girls initiating depot medroxyprogesterone, oral contraceptive pills, or no hormonal contraceptive method","volume":"160","author":"Bonny","year":"2006","journal-title":"Arch Pediatr Adolesc Med"},{"key":"R44-20260916","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.contraception.2005.12.010","article-title":"Progestogen-only contraception and bone mineral density: a systematic review","volume":"73","author":"Curtis","year":"2006","journal-title":"Contraception"},{"key":"R45-20260916","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.contraception.2007.10.005","article-title":"Bone density recovery after depot medroxyprogesterone acetate injectable contraception use","volume":"77","author":"Kaunitz","year":"2008","journal-title":"Contraception"},{"key":"R46-20260916","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1097\/01.AOG.0000450758.95422.c8","article-title":"Depot medroxyprogesterone acetate and bone effects. Committee Opinion No. 602. American College of Obstetricians and Gynecologists","volume":"123","year":"2014","journal-title":"Obstet Gynecol"},{"key":"R47-20260916","first-page":"777","article-title":"Role of the levonorgestrel intrauterine system in effective contraception","volume":"7","author":"Attia","year":"2013","journal-title":"Patient Prefer Adherence"},{"key":"R48-20260916","doi-asserted-by":"crossref","first-page":"586.e1","DOI":"10.1016\/j.ajog.2017.01.036","article-title":"Prolonged use of the etonogestrel implant and levonorgestrel intrauterine device: 2 years beyond Food and Drug Administration-approved duration","volume":"216","author":"McNicholas","year":"2017","journal-title":"Am J Obstet Gynecol"},{"issue":"RR-4","key":"R49-20260916","first-page":"1","article-title":"U.S. selected practice recommendations for contraceptive use, 2016","volume":"65","author":"Curtis","year":"2016","journal-title":"MMWR Recomm Rep"},{"key":"R50-20260916","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1080\/13625187.2016.1210122","article-title":"Combined oral contraceptive treatment for bleeding complaints with the etonogestrel contraceptive implant: a randomised controlled trial","volume":"21","author":"Hou","year":"2016","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"R52-20260916","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1089\/heq.2020.0025","article-title":"Implicit bias in counseling for permanent contraception: historical context and recommendations for counseling","volume":"4","author":"Kathawa","year":"2020","journal-title":"Health Equity"},{"key":"R53-20260916","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1097\/AOG.0000000000004247","article-title":"Informed consent and shared decision making in obstetrics and gynecology. ACOG Committee Opinion No. 819. American College of Obstetricians and Gynecologists","volume":"137","year":"2021","journal-title":"Obstet Gynecol"},{"key":"R54-20260916","doi-asserted-by":"crossref","first-page":"e143","DOI":"10.1097\/AOG.0000000000001215","article-title":"Menstruation in girls and adolescents: using the menstrual cycle as a vital sign. Committee Opinion No. 651. American College of Obstetricians and Gynecologists","volume":"126","year":"2015","journal-title":"Obstet Gynecol"},{"key":"R55-20260916","doi-asserted-by":"crossref","first-page":"e171","DOI":"10.1097\/AOG.0000000000003770","article-title":"Confidentiality in adolescent health care. ACOG Committee Opinion No. 803. American College of Obstetricians and Gynecologists","volume":"135","year":"2020","journal-title":"Obstet Gynecol"},{"key":"R56-20260916","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00404-016-4261-0","article-title":"Usage of the levonorgestrel-releasing intrauterine system (LNG-IUS) in adolescence: what is the evidence so far?","volume":"295","author":"Patseadou","year":"2017","journal-title":"Arch Gynecol Obstet"},{"key":"R57-20260916","doi-asserted-by":"crossref","first-page":"e130","DOI":"10.1097\/AOG.0000000000002632","article-title":"Adolescents and long-acting reversible contraception: implants and intrauterine devices. ACOG Committee Opinion No. 735. American College of Obstetricians and Gynecologists","volume":"131","year":"2018","journal-title":"Obstet Gynecol"},{"key":"R58-20260916","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1080\/13691058.2016.1182645","article-title":"Queer periods: attitudes toward and experiences with menstruation in the masculine of centre and transgender community","volume":"18","author":"Chrisler","year":"2016","journal-title":"Cult Health Sex"},{"key":"R59-20260916","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1097\/AOG.0000000000004294","article-title":"Health care for transgender and gender diverse individuals. ACOG Committee Opinion No. 823. American College of Obstetricians and Gynecologists","volume":"137","year":"2021","journal-title":"Obstet Gynecol"},{"key":"R60-20260916","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1080\/15532739.2019.1631929","article-title":"Hormonal contraceptive choices in a clinic-based series of transgender adolescents and young adults","volume":"20","author":"Kanj","year":"2019","journal-title":"Int J Transgend"},{"key":"R61-20260916","doi-asserted-by":"crossref","first-page":"578","DOI":"10.5694\/mja12.10222","article-title":"Hormone treatment of gender identity disorder in a cohort of children and adolescents","volume":"196","author":"Hewitt","year":"2012","journal-title":"Med J Aust"},{"key":"R62-20260916","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.jpag.2021.04.004","article-title":"Breakthrough bleeding in transgender and gender diverse adolescents and young adults on long-term testosterone","volume":"34","author":"Grimstad","year":"2021","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"R63-20260916","doi-asserted-by":"crossref","first-page":"e64","DOI":"10.3928\/19382359-20190116-04","article-title":"The reproductive health care of transgender young people: a guide for primary care providers","volume":"48","author":"Dodson","year":"2019","journal-title":"Pediatr Ann"},{"key":"R64-20260916","first-page":"100684","article-title":"Sexual and reproductive health considerations among transgender and gender-expansive youth","volume":"49","author":"Mehringer","year":"2019","journal-title":"Curr Probl Pediatr Adolesc Health Care"},{"key":"R65-20260916","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jpag.2005.03.002","article-title":"Menstrual and contraceptive issues among young women with developmental delay: a retrospective review of cases at the Hospital for Sick Children, Toronto","volume":"18","author":"Dizon","year":"2005","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"R66-20260916","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1097\/JXX.0000000000000468","article-title":"Menstrual suppression in girls with disabilities","volume":"33","author":"Hopkins","year":"2021","journal-title":"J Am Assoc Nurse Pract"},{"key":"R67-20260916","doi-asserted-by":"crossref","first-page":"e20160295","DOI":"10.1542\/peds.2016-0295","article-title":"Menstrual management for adolescents with disabilities. Committee on Adolescence, North American Society for Pediatric and Adolescent Gynecology","volume":"138","author":"Quint","year":"2016","journal-title":"Pediatrics"},{"key":"R68-20260916","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jpag.2015.05.003","article-title":"Adolescents with special needs: clinical challenges in reproductive health care","volume":"29","author":"Quint","year":"2016","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"R69-20260916","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ijgo.2011.07.003","article-title":"Ethical issues in the management of severely disabled women with gynecologic problems","volume":"115","year":"2011","journal-title":"Int J Gynaecol Obstet"},{"key":"R70-20260916","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1542-2011.2011.00115.x","article-title":"Women's health and hygiene experiences during deployment to the Iraq and Afghanistan wars, 2003 through 2010","volume":"57","author":"Doherty","year":"2012","journal-title":"J Midwifery Womens Health"},{"key":"R71-20260916","doi-asserted-by":"crossref","first-page":"645","DOI":"10.7205\/MILMED-D-13-00302","article-title":"Reproductive health access among deployed U.S. servicewomen: a qualitative study","volume":"179","author":"Manski","year":"2014","journal-title":"Mil Med"},{"key":"R72-20260916","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1552-6909.2007.00166.x","article-title":"Military women's menstrual experiences and interest in menstrual suppression during deployment","volume":"36","author":"Trego","year":"2007","journal-title":"J Obstet Gynecol Neonatal Nurs"},{"key":"R73-20260916","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1097\/01.AOG.0000423821.70036.5a","article-title":"Health care for women in the military and women veterans. Committee Opinion No. 547. American College of Obstetricians and Gynecologists","volume":"120","year":"2012","journal-title":"Obstet Gynecol"},{"key":"R74-20260916","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12978-021-01133-8","article-title":"Seeking menstrual products: a qualitative exploration of the unmet menstrual needs of individuals experiencing homelessness in New York City","volume":"18","author":"Gruer","year":"2021","journal-title":"Reprod Health"},{"key":"R75-20260916","doi-asserted-by":"crossref","first-page":"e0252946","DOI":"10.1371\/journal.pone.0252946","article-title":"Public restrooms, periods, and people experiencing homelessness: an assessment of public toilets in high needs areas of Manhattan, New York","volume":"16","author":"Maroko","year":"2021","journal-title":"PLoS One"},{"key":"R76-20260916","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1108\/IJPH-07-2016-0031","article-title":"Evidence-based recommendations to improve reproductive healthcare for incarcerated women","volume":"13","author":"Knittel","year":"2017","journal-title":"Int J Prison Health"},{"key":"R77-20260916","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jadohealth.2013.04.014","article-title":"Trends in menstrual concerns and suppression in adolescents with developmental disabilities","volume":"53","author":"Kirkham","year":"2013","journal-title":"J Adolesc Health"},{"key":"R78-20260916","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0010-7824(03)00141-0","article-title":"A multicenter, randomized study of an extended cycle oral contraceptive [published erratum appears in Contraception 2004;69:175]","volume":"68","author":"Anderson","year":"2003","journal-title":"Contraception"}],"updated-by":[{"DOI":"10.1097\/aog.0000000000005460","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000}}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000004899","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T11:02:14Z","timestamp":1789556534000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000004899"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":68,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000004899","relation":{},"ISSN":["0029-7844","1873-233X"],"issn-type":[{"value":"0029-7844","type":"print"},{"value":"1873-233X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9]]}}}